Does TALICIA Interact with other Medications?

Severe Interactions

These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

  • RIFABUTIN/INTRAMUSCULAR RILPIVIRINE
  • CYP3A4 & UGT1A1 INDUCERS/CABOTEGRAVIR-RILPIVIRINE
  • STRONG AND MODERATE CYP3A4 INDUCERS/LONAFARNIB
  • RIFABUTIN/SOFOSBUVIR-CONTAINING HEPATITIS C PRODUCTS
  • SLT STRONG & MODERATE CYP2C19 INHIBITORS/CILOSTAZOL (> 50MG)
  • SLT MODERATE-STRONG CYP3A4 INDUCERS/SLT HEPATITIS C AGENTS
  • PROTON PUMP INHIBITORS/RILPIVIRINE
  • SELECTED CYP3A4 INDUCERS/NIFEDIPINE
  • STRONG CYP3A4 INDUCERS/RANOLAZINE
  • PROTON PUMP INHIBITORS/ATAZANAVIR; NELFINAVIR
  • SELECTED CYP3A4 INDUCERS/ISAVUCONAZONIUM; VORICONAZOLE
  • RIFAMPIN; RIFABUTIN/DELAVIRDINE
  • ANTIMICROBIALS/LIVE TYPHOID VACCINE
  • Serious Interactions

    These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

  • RIFAMYCINS/SELECTED ANTICOAGULANTS (VITAMIN K ANTAGONISTS)
  • RIFAMYCINS/CLARITHROMYCIN; ERYTHROMYCIN; TELITHROMYCIN
  • RIFABUTIN/ETRAVIRINE
  • RIFABUTIN/NIRMATRELVIR
  • STRONG OR MODERATE CYP3A4 INDUCERS/GANAXOLONE
  • MODERATE CYP3A4 INDUCERS/PACRITINIB
  • H2 ANTAGONISTS; PROTON PUMP INHIBITORS/LEVOKETOCONAZOLE
  • RIFABUTIN/INTRAMUSCULAR CABOTEGRAVIR
  • STRONG OR MODERATE CYP3A4 INDUCERS/AVACOPAN
  • STRONG OR MODERATE CYP3A4 INDUCERS/MOBOCERTINIB
  • STRONG AND MODERATE CYP3A4 INDUCERS/FEXINIDAZOLE
  • H2 ANTAGONISTS;PROTON PUMP INHIBITORS/METHYLPHENIDATE XR-ODT
  • STRONG AND MODERATE CYP3A4 INDUCERS/FINERENONE
  • MODERATE CYP3A4 AND P-GP INDUCERS/GLECAPREVIR-PIBRENTASVIR
  • MODERATE CYP3A4 INDUCERS/RIPRETINIB
  • STRONG AND MODERATE CYP3A4 INDUCERS/IBREXAFUNGERP
  • PROTON PUMP INHIBITORS/INFIGRATINIB
  • H2 ANTAGONISTS; PROTON PUMP INHIBITORS/SOTORASIB
  • STRONG AND MODERATE CYP3A4 INDUCERS/INFIGRATINIB
  • PROTON PUMP INHIBITORS/INDINAVIR
  • RIFABUTIN/VOXELOTOR
  • RIFABUTIN/LETERMOVIR
  • SELECTED MODERATE CYP3A4 INDUCERS/CRIZOTINIB
  • STRONG AND MODERATE CYP3A4 INDUCERS/VOCLOSPORIN
  • MODERATE CYP3A4 INDUCERS/IDELALISIB
  • LONG ACTING ANTACIDS; H2S;PPIS/SELECTED CEPHALOSPORINS
  • STRONG AND MODERATE CYP3A4 INDUCERS/LURBINECTEDIN
  • STRONG AND MODERATE CYP3A4 INDUCERS/SELPERCATINIB
  • STRONG AND MODERATE CYP3A4 INDUCERS/CAPMATINIB
  • STRONG AND MODERATE CYP3A4 INDUCERS/PEMIGATINIB
  • STRONG AND MODERATE CYP3A4 INDUCERS/SELUMETINIB
  • MODERATE CYP3A4 INDUCERS/GLASDEGIB
  • STRONG AND MODERATE CYP3A4 INDUCERS/RIMEGEPANT
  • STRONG OR MODERATE CYP3A4 INDUCERS/TAZEMETOSTAT
  • RIFABUTIN/ABIRATERONE; CABAZITAXEL; VINCRISTINE
  • MODERATE CYP3A4 INDUCERS/IBRUTINIB
  • RIFABUTIN/SELECTED ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS
  • STRONG OR MODERATE CYP3A4 INDUCERS/AVAPRITINIB
  • CYP3A4 INDUCERS/LUMATEPERONE
  • STRONG OR MODERATE CYP3A4 INDUCERS/DARIDOREXANT; LEMBOREXANT
  • STRONG OR MODERATE CYP3A4 INDUCERS/ZANUBRUTINIB
  • MODERATE CYP3A4 INDUCERS/LEFAMULIN
  • MODERATE CYP3A4 INDUCERS/FEDRATINIB
  • MODERATE CYP3A4 INDUCERS/ENTRECTINIB
  • STRONG AND MODERATE CYP3A4 INDUCERS/PRETOMANID
  • P-GP AND MODERATE CYP3A4 INDUCERS/DAROLUTAMIDE
  • H2 ANTAGONISTS; PROTON PUMP INHIBITORS/SECRETIN
  • SELECTED STRONG CYP3A4 INDUCERS; RIFABUTIN/BICTEGRAVIR
  • SELECTED MODERATE CYP2C9 OR CYP3A4 INDUCERS/ERDAFITINIB
  • SELECTED MODERATE AND STRONG CYP3A4 INDUCERS/SIPONIMOD
  • STRONG CYP3A4 INDUCERS; RIFABUTIN/LAROTRECTINIB
  • MODERATE CYP3A4 INDUCERS/LORLATINIB
  • RIFABUTIN/DORAVIRINE
  • MODERATE CYP3A4 INDUCERS/ABEMACICLIB
  • STRONG AND MODERATE CYP3A4 INDUCERS/ENCORAFENIB
  • PROTON PUMP INHIBITORS/ACALABRUTINIB
  • STRONG AND MODERATE CYP3A4 INDUCERS/NERATINIB
  • STRONG CYP3A4 INDUCERS; RIFABUTIN/BRIGATINIB
  • PROTON PUMP INHIBITORS/CAPECITABINE
  • MODERATE CYP3A4 INDUCERS/VENETOCLAX
  • RIFABUTIN/ORAL RILPIVIRINE
  • STRONG CYP3A4 INDUCERS; RIFABUTIN/VEMURAFENIB
  • MODERATE CYP3A4 INDUCERS/ELBASVIR-GRAZOPREVIR
  • SLT MODERATE AND STRONG CYP3A4 INDUCERS/IXAZOMIB
  • STRONG CYP3A4 INDUCERS/FLIBANSERIN
  • PROTON PUMP INHIBITORS/LEDIPASVIR; VELPATASVIR
  • STRONG & MODERATE CYP3A4 INDUCERS/GUANFACINE
  • STRONG OR MODERATE CYP3A4 INDUCERS/SIMEPREVIR
  • MODERATE CYP3A4 INDUCERS/BOSUTINIB
  • STRONG; SELECTED MODERATE CYP2C19 INHIBITORS/CLOBAZAM
  • STRONG & MODERATE CYP3A4 INDUCERS/BEDAQUILINE
  • STRONG CYP3A4 INDUCERS; RIFABUTIN/PONATINIB
  • SELECTED CYP3A4 INDUCERS/COBICISTAT-ELVITEGRAVIR
  • PROTON PUMP INHIBITORS/METHOTREXATE (ONCOLOGY-INJECTION )
  • STRONG & MODERATE CYP3A4 INDUCERS/SELECTED ANTINEOPLASTICS
  • SELECT CYP2C19 INHIBITORS/CITALOPRAM (>20 MG)
  • STRONG CYP3A4 INDUCERS/TOREMIFENE
  • STRONG P-GP OR CYP3A4 INDUCER/LINAGLIPTIN
  • P-GLYCOPROTEIN (P-GP) INDUCERS/DABIGATRAN
  • RIFAMPIN; RIFABUTIN/IXABEPILONE
  • STRONG CYP3A4 INDUCERS; RIFABUTIN/ROMIDEPSIN
  • RIFAMYCINS/ULIPRISTAL
  • STRONG CYP3A4 INDUCERS/TOLVAPTAN
  • STRONG CYP3A4 INDUCERS/SELECTED IMMUNOSUPPRESSANTS
  • ESOMEPRAZOLE; OMEPRAZOLE; CIMETIDINE/CLOPIDOGREL
  • SELECTED ANTIMYCOBACTERIALS/LIVE BCG
  • CIMETIDINE; PROTON PUMP INHIBITORS/POSACONAZOLE SUSPENSION
  • SELECTED STRONG CYP3A4 INDUCERS/IRINOTECAN
  • PROTON PUMP INHIBITORS/SELECTED KINASE INHIBITORS
  • RIFAMYCINS/POSACONAZOLE
  • PENICILLINS/METHOTREXATE
  • RIFAMYCINS/THEOPHYLLINE
  • RIFAMYCINS/SELECTED CALCIUM CHANNEL BLOCKERS
  • RIFABUTIN; RIFAPENTINE/SELECTED PROTEASE INHIBITORS
  • RIFAMYCINS/HORMONAL CONTRACEPTIVES
  • Moderate Interactions

    These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.

  • SELECTED CEPHALOSPORINS & PENICILLINS/PROBENECID
  • OMEPRAZOLE/VORICONAZOLE
  • RIFABUTIN/EFAVIRENZ
  • SLT PROTON PUMP INHIBITORS/SELECT CYP2C19 AND CYP3A4 INDUCER
  • ESOMEPRAZOLE; OMEPRAZOLE/CARBAMAZEPINE
  • MODERATE CYP3A4 INDUCERS/MITAPIVAT
  • MODERATE CYP3A4 INDUCERS/DUVELISIB
  • SLT MODERATE AND WEAK CYP3A4 INHIBIT/SIROLIMUS PROTEIN-BOUND
  • STRONG AND MODERATE CYP3A4 INDUCERS/ATOGEPANT
  • PROTON PUMP INHIBITORS/BELUMOSUDIL
  • RIFAMYCINS/DAPSONE
  • RIFABUTIN/AZOLE ANTIFUNGAL AGENTS
  • SELECTED P-GP INDUCERS/BEROTRALSTAT
  • PROTON PUMP INHIBITORS/SELPERCATINIB
  • MODERATE CYP3A4 INDUCERS/ROLAPITANT
  • MODERATE AND WEAK CYP3A4 INDUCERS/UBROGEPANT
  • SELECTED P-GLYCOPROTEIN (P-GP) INDUCERS/BETRIXABAN
  • SLT STRONG & MODERATE CYP2C19 INHIBITORS/CILOSTAZOL (<=50MG)
  • SELECTED CYP2C19 INHIBITORS/ESCITALOPRAM (<= 15 MG)
  • STRONG AND MODERATE CYP3A4 INDUCERS/PERAMPANEL
  • P-GLYCOPROTEIN (P-GP) INDUCERS/ETOPOSIDE
  • RIFAMYCINS/ESTROGEN REPLACEMENT THERAPY
  • STRONG AND MODERATE CYP3A4 INDUCERS/PIMAVANSERIN
  • SELECTED P-GP INDUCERS; PHENOBARBITAL/TENOFOVIR ALAFENAMIDE
  • SELECTED P-GLYCOPROTEIN (P-GP) INDUCERS/EDOXABAN
  • MODERATE CYP3A4 INDUCERS/DACLATASVIR
  • SELECTED MODERATE-WEAK CYP3A4 INDUCERS/EXEMESTANE
  • P-GLYCOPROTEIN (P-GP) INDUCERS; PHENOBARBITAL/AFATINIB
  • PROTON PUMP INHIBITORS/SAQUINAVIR
  • SELECTED CYP2C19 INHIBITORS/ESCITALOPRAM (> 15 MG)
  • SELECTED CYP2C19 INHIBITORS/CITALOPRAM (<= 20 MG)
  • SELECTED PROTON PUMP INHIBITORS/TACROLIMUS
  • PROTON PUMP INHIBITORS/MYCOPHENOLATE MOFETIL
  • SELECTED CYP3A4 INDUCERS/SELECTED BENZODIAZEPINES
  • PROTON PUMP INHIBITORS/METHOTREXATE(LOW STRENGTH INJ, ORAL)
  • ANTACIDS;H2 ANTAGONISTS;PROTON PUMP INHIBITORS/AMPHETAMINES
  • RIFABUTIN/ERYTHROMYCIN
  • RIFABUTIN/ATOVAQUONE
  • SELECTED PENICILLINS/SELECTED ANTICOAGULANTS (VIT K ANTAG)
  • OMEPRAZOLE/HYDANTOINS
  • AGENTS AFFECTING GASTRIC PH/ITRACONAZOLE; KETOCONAZOLE
  • RIFAMYCINS/BETA-BLOCKERS, ORAL
  • PENICILLINS/ORAL CONTRACEPTIVES
  • RIFAMYCINS/DIGITALIS GLYCOSIDES
  • RIFAMYCINS/DISOPYRAMIDE; MEXILETINE; PROPAFENONE
  • RIFAMYCINS/PIOGLIT; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA
  • SELECTED CYP3A4 INDUCERS/CORTICOSTEROIDS
  • Drug Survey

    Are you currently using Talicia?

    This survey is being conducted by the WebMD marketing sciences department.

    Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

    CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.